Purchase Order 75N93021P00261
Award Date 1/20/21
Potential Completion Date 1/19/22
Potential Value $340K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide a NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 research. The $338,350.00 contract has a completion date of September 25, 2020 and was awarded on June 22, 2020 with no set-aside designation. Illumina has previously provided sequencing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $340,025 firm fixed price purchase order to Illumina, Inc. to deliver one NextSEQ2000 genome sequencer to the Laboratory of Parasitic Diseases. The sequencer will support the laboratory's SARS-CoV-2 and other research efforts. As the prime contractor, Illumina will furnish the requested high-throughput sequencer from its San Diego, California location by the end date of October 25, 2021 to meet...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the NextSeq 1000 Sequencing System. The $213,150.00 contract supports NIAID's Vaccine Immunology Program's research into monoclonal antibodies and vaccines for infectious diseases such as HIV, influenza, Ebola, and SARS-CoV-2....
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Illumina, Inc. for the purchase of NextSeq and NovaSeq DNA sequencing systems, reagents, and related consumables. The $35,233.70 order supports genomic sequencing and analysis work, with a period of performance through March 2025. Illumina, a manufacturer of sequencing and array-based solutions, has...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,021.25 firm fixed price purchase order to Illumina, Inc. to procure one mid-throughput next generation sequencing instrument or equal. The solicitation sought a sequencing instrument with flowcell options ranging from 100 million to 1.2 billion reads and an onboard bioinformatics server, to be delivered by December 28, 2023 to the Vaccine Research Center...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $341,700.00 firm fixed price purchase order to Illumina, Inc. for the NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 response efforts. The award was made on August 17, 2020 with a completion date of December 31, 2020. Illumina is a manufacturer and provider of sequencing and array-based genomic analysis solutions, and has a history of providing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for a NextSeq 550 Sequencing System and associated support services. The potential value of the contract is $316,250.00. There was no set-aside used for this award. The contract was issued under the statutory authority of 41 U.S.C. 253 (c) (1), citing only one source available for...